Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms

Official Title

Brief Summary

Three hundred healthcare workers with mild symptoms for Covid-19 will be followed during three months. Each two weeks, serological tests will be performed. Re-infection will be monitored by saliva-swabs.

Status

Completed

Conditions

COVID-19

Serology

Eligibility Criteria

Inclusion Criteria:

- HCW previous tested for Covid-19 with mild symptoms in Jessa Ziekenhuis, Belgium

Exclusion Criteria:

-

Eligibility Gender

All

Eligibility Age

Minimum: 18 Years ~ Maximum: 70 Years

Countries

Belgium

Locations

Sciensano
Brussels, Belgium

Investigators

Maria Goossens, MD, PhD, Principal Investigator
Sciensano

NCT Number

NCT04356586

MeSH Terms

COVID-19

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Jessa Hospital

Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA